240
Participants
Start Date
October 31, 2013
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
PF-02545920
PF-02545920 2 mg BID x 7 days, then 5 mg BID until the Week 12 visit
Placebo
Placebo BID until the Week 12 visit
PF-02545920
PF-02545920 5 mg BID x 7 days, then 10 mg BID x 7 days, then 15 mg BID until the Week 12 visit
Manhattan Psychiatric Center's 125th St. Clinic, New York
Manhattan Psychiatric Center, Ward's Island
Comprehensive Clinical Development, Jamaica
Comprehensive Clinical Development, Washington D.C.
CBH Health, LLC, Rockville
Comprehensive Clinical Development, Inc., Atlanta
Medical Research Group of Central Florida, Sanford
Innovative Clinical Research, Inc., Lauderhill
Florida Clinical research Center, LLC, Brandenton
Florida Clinical Research Center, LLC, Bradenton
Birmingham Psychiatry Pharmaceutical Studies, Inc., Birmingham
Research Strategies of Memphis, LLC, Memphis
Midwest Clinical Research Center, LLC, Dayton
Alexian Brothers Center for Psychiatric Research, Hoffman Estates
Chinmay K. Patel, DO, Hoffman Estates
Behavioral Health Care Associates, Schaumburg
St. Louis Clinical Trials/The Summit@Creve Coeur, St Louis
Psychiatric Care & Research Center, O'Fallon
Lake Charles Clinical Trials, Lake Charles
Louisiana Clinical Research, Shreveport
Woodland International Research Group, INC, Little Rock
Cutting Edge Research Group, Oklahoma City
InSite Clinical Research, DeSoto
Futuresearch Trials of Dallas, Dallas
Pillar Clinical Research LLC, Dallas
FutureSearch Trials, Austin
Community Clinical Research, Inc, Austin
Psychiatric and Behaviorial Solutions, Salt Lake City
Lifetree Clinical Research, Salt Lake City
Altea Research, Las Vegas
ProScience Research Group, Culver City
Collaborative Neuroscience Network, Inc., Torrance
Comprehensive Clinical Development, Inc., Cerritos
Synergy Clinical Research of Escondido, Escondido
Excell Research, Inc., Oceanside
CNRI-San Diego, LLC, San Diego
Sharp Mesa Vista Hospital, San Diego
CiTrials, Riverside
Collaborative Neuroscience Network, Inc., Garden Grove
Neuropsychiatric Research Center of Orange County, Orange
Pacific Research Partners, Oakland
Bliss Basement Pharmacy, Hartford
Institute of Living, Hartford
Yale University, New Haven
Lead Sponsor
Pfizer
INDUSTRY